Physicochemical and safety evaluation of 5-aminolevulinic acid in novel liposomes as carrier for skin delivery

Journal of Liposome Research

Volumn 18, Issue 1, 2008, Pages 31-45

  Fang, Yi Ping ^a   Wu, Pao Chu ^a   Tsai, Yi Hung ^a   Huang, Yaw Bin ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

5 Aminolevulinic acid; Entrapment efficiency; Liposomes; Penetration; Photodynamic therapy; Safety

Indexed keywords

AMINOLEVULINIC ACID; AMPHOLYTE; CHOLESTEROL; LIPOSOME; OLEATE SODIUM; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; POTASSIUM STEARIC ACID; SODIUM STEARIC ACID; STEARIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG POTENCY; DRUG RELEASE; DRUG SAFETY; HEMOLYSIS; HUMAN; HUMAN CELL; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; STRATUM CORNEUM;

AMINOLEVULINIC ACID; ANIMALS; CHOLESTEROL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FIBROBLASTS; HUMANS; IONS; LIPOSOMES; MODELS, BIOLOGICAL; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; SAFETY; SKIN; STEARATES;

EID: 40949159792     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.1080/08982100801893952     Document Type: Article

References (40)

1. Bjerregaard, S., Wulf-Andersen, L., Stephens, R. W., Roge, L. L., Vermehren, C., Soderberg, I., and Frokjaer, S. 2001. Sustained elevated plasma aprotinin concentration in mice following intraperitoneal injections of w/o emulsions incorporating aprotinin. J. Control. Release, 71:87-98.
2. Casas, A., Fukuda, H., Di Venosa, G., and Batlle, A. M. 2000. The influence of the vehicle on the synthesis of porphyrins after topical application of 5-aminolaevulinic acid. Implications in cutaneous photodynamic sensitization. Br. J. Dermatol., 143:564-72.
3. Casas, A., Perotti, C., Saccoliti, M., Sacca, P., Fukuda, H., and Batlle, A. M. 2002. ALA and ALA hexyl ester in free and liposomal formulations for the photosensitisation of tumour organ cultures. Br. J. Cancer, 86:837-42.
4. Cevc, G. and Blume, G. 1992. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim. Biophys. Acta, 1104:226-32.
5. De Rosa, F. S. and Bentley, M. V. 2000. Photodynamic therapy of skin cancers: sensitizers, clinical studies and future directives. Pharm. Res., 17:1447-55.
6. Derycke, A. S. and de Witte, P. A. 2004. Liposomes for photodynamic therapy. Adv. Drug Deliver., Rev. 56:17-30.
7. Du Plessis, J., Ramachandran, C., Weiner, N., and Müller, D. G. 1994. The influence of particle size of liposomes on the disposition of drug into the skin. Int. J. Pharm., 103:277-82.
8. El Maghraby, G. M., Williams, A. C., and Barry, B. W. 2000. Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. Int. J. Pharm., 204:159-69.
9. Fang, J. Y., Hung, C. F., Hwang, T. L., and Huang, Y. L. 2005. Physicochemical characteristics and in vivo deposition of liposome-encapsulated tea catechins by topical and intratumor administrations. J. Drug Target., 13:19-27.
10. Fang, J. Y., Hwang, T. L., Huang, Y. L., and Fang, C. L. 2006. Enhancement of the transdermal delivery of catechins by liposomes incorporating anionic surfactants and ethanol. Int. J. Pharm., 9:131-8.
11. Fang, J. Y., Lee, W. R., Shen, S. C., Fang, Y. P., and Hu, C. H. 2004. Enhancement of topical 5-aminolaevulinic acid delivery by erbium:YAG laser and microdermabrasion: a comparison with iontophoresis and electroporation. Br. J. Dermatol., 151:132-40.
12. Fang, J. Y., Lin, H. H., Hsu, L. R., and Tsai, Y. H. 1997. Characterization and stability of various liposome-encapsulated enoxacin formulations. Chem. Pharm. Bull., 45:1504-9.
13. Fotinos, N., Campo, M. A., Popowycz, F., Gurny, R., and Lange, N. 2006. 5-aminolevulinic acid derivatives in photomedicine: basics, application and perspectives. Photochem Photobiol., 82: 994-1015.
14. Francoeur, M. L., Golden, G. M., and Potts, R. O. 1990. Oleic acid: its effects on stratum corneum in relation to (trans)dermal drug delivery. Pharm. Res., 7:621-7.
15. Fukuda, H., Paredes, S., and Batlle, A. M. 1989. Tumor-localizing properties of porphyrins. In vitro studies using the porphyrin precursor, aminolevulinic acid, in free and liposome encapsulated forms. Drug Des. Deliv., 5:133-9.
16. Fuller, N. and Rand, R. P. 2001.The influence of lysolipids on the spontaneous curvature and bending elasticity of phospholipid membranes. Biophys. J., 81:243-54.
17. Hurlimann, A. F., Hanggi, G., and Panizzon, R. G. 1998. Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolevulinic acid in a nanocolloid lotion. Dermatology, 197: 248-54.
18. Kakehashi, R., Shizuma, M., Yamamura, S., and Takeda, T. 2004. Mixed micelles containing sodium oleate: the effect of the chain length and the polar head group. J. Colloid Interf. Sci., 279: 253-58.
19. Kirjavainen, M., Urtti, A., Jääskeläinen, I., Suhonen, M., Paronen, P., Valjakka-Koskela, R., Kiesvaara, J., and Mönkkönen, J. 1996. Interaction of liposomes with human skin in vitro - the influence of lipid composition and structure. Biochim. Biophys. Acta, 1304:179-89.
20. Kirjavainen, M., Urtti, A., Valjakka-Koskela, R., Kiesvaara, J., and Mönkkönen, J. 1999. Liposome-skin interactions and their effects on the skin permeation of drugs. Eur. J. Pharm. Sci., 7:279-86.
21. Kosobe, T., Moriyama, E., Tokuoka, Y., and Kawashima, N. 2005. Size and surface charge effect of 5-aminolevulinic acid-containing liposomes on photodynamic therapy for cultivated cancer cells. Drug Dev. Ind. Pharm., 31:623-29.
22. Maestrelli, F., Gonzalez-Rodriguez, M. L., Rabasco, A. M., and Mura, P. 2005. Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery. Int. J. Pharm., 298:55-67.
23. Marjukka, S. T., Bouwstra, J. A., and Urtti, A. 1999. Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations. J. Control. Release, 59:149-61.
24. McConnell, H.M. and Radhakrishnan, A. 2003. Condensed complexes of cholesterol and phospholipids. Biochim. Biophys. Acta, 1610:159-73.
25. Merclin, N., Bender, J., Sparr, E., Guy, R. H., Ehrsson, H., and Engstrom, S. 2004. Transdermal delivery from a lipid sponge phase-iontophoretic and passive transport in vitro of 5-aminolevulinic acid and its methyl ester. J. Control. Release, 100:191-8.
26. Morton, C. A., Brown, S. B., Collins, S., Ibbotson, S., Jenkinson, H., Kurwa, H., Langmack, K., McKenna, K., Moseley, H., Pearse, A. D., Stringer, M., Taylor, D. K., Wong, G., and Rhodes, L. E. 2002. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br. J. Dermatol., 146:552-67.
27. Nagasaka, Y. and Ishii, F. 2001. Interaction between erythrocytes from three different animals and emulsions prepared with various lecithins and oils. Colloids Surf. B. Biointerfaces, 22:141-7.
28. Nagayasu, A., Uchiyama, K., and Kiwada, H. 1999. The size of liposomes: A factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. Adv. Drug Deliver. Rev., 10:75-87.
29. Oishi, H., Nomiyama, H., Nomiyama, K., and Tomokuni, K. 1996. Fluorometric HPLC determination of delta-aminolevulinic acid (ALA) in the plasma and urine of lead workers: biological indicators of lead exposure. J. Anal. Toxicol., 20:106-10.
30. Oku, N. 1999. Anticancer therapy using glucuronate modified long-circulating liposomes. Adv. Drug Deliv., Rev. 40:63-73.
31. Peng, Q., Berg, K., Moan, J., Kongshaug, M., and Nesland, J. M. 1997. 5-aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem. Photobiol., 65:235-51.
32. Sung, K. C., Fang, J. Y., and Hu, O. Y. 2000. Delivery of nalbuphine and its prodrugs across skin by passive diffusion and iontophoresis. Journal of Controlled Release, 67:1-8.
33. Sung, K. C., Fang, J. Y., Wang, J. J., and Hu, O. Y. 2003. Transdermal delivery of nalbuphine and its prodrugs by electroporation. Eur. J. Pharm. Sci., 18:63-70.
34. Weiner, N., Williams, N., Birch, G., Ramachandran, C., Shipman, C. J., and Flynn, G. 1989. Topical delivery of liposomally encapsulated interferon evaluated in a cutaneous herpes guinea pig model. Antimicrob. Agents Chemother., 33:1217-21.
35. Williams, A. C. and Barry, B. W. 1992. Skin absorption enhancers. Crit. Rev. Ther. Drug Carrier Syst., 9:305-53.
36. Yatvin, M. B. and Lelkes, P. I. 1982. Clinical prospects for liposomes. Med. Phys., 9:149-75.
37. van den Bergh, B. A. I., Vroom, J., Gerritsen, H., Junginger, H. E., and Bouwstra, J. A. 1999. Interactions of elastic and rigid vesicles with human skin in vitro: electron microscopy and two-photon excitation microscopy. Biochim. Biophys. Acta, 1461: 155-73.
38. van Kuijk-Meuwissen, M. E. Mougin, L., Junginger, H. E., and Bouwstra, J. A. 1998. Application of vesicles to rat skin in vivo: a confocal laser scanning microscopy study. J. Control. Release, 56: 189-96.
39. Verma, D. D. and Fahr, A. 2004. Synergistic penetration enhancement effect of ethanol and phospholipids on the topical delivery of cyclosporin A. J. Control. Release, 97:55-66.
40. Verma, D. D., Verma, S., Blume, G., and Fahr, A. 2003. Particle size of liposomes influences dermal delivery of substances into skin. Int. J. Pharm., 258:141-51.